Physician profile
Sofia Bernabe
NPI 1811421985
$5,261.17
in general payments reported to CMS, 2019-2025
11 companies · $1,211 in 2025
The $1,211 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $889 · 2020: $32.59 · 2021: $111 · 2022: $1,124 · 2023: $1,551 · 2024: $343 · 2025: $1,211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,081 · Travel and Lodging: $24.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,080.96 |
| Travel and Lodging | $24.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,356.03 | 2022-2025 | Infuse, Miebo, Xiidra |
| Alcon Vision LLC | $890.94 | 2019-2025 | Clareon, Precision7, Total30 |
| Coopervision INC. | $725.70 | 2020-2025 | Myday Contact Lens |
| Glaukos Corporation | $565.72 | 2023-2025 | Kxl1b-Ce-Marked Kxlsystem, Kxl System (Not Refurbished), Photrexa Viscous and Photrexa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $529.73 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $475.33 | 2019-2025 | Acuvue |
| Biotissue Holdings INC. | $203.49 | 2022-2023 | |
| Sight Sciences, INC. | $148.42 | 2022 | |
| Sun Pharmaceutical Industries INC. | $124.98 | 2022 | |
| Shire North American Group INC | $122.34 | 2019 | |
| Visionix USA, INC | $118.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sofia Bernabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.